MedPath

The effect of GRAIL training on functional walking capacity and social participation in patients with incomplete spinal cord injury.

Completed
Conditions
10041543
incomplete spinal cord injury
partial paralysis
Registration Number
NL-OMON48297
Lead Sponsor
Sint Maartenskliniek
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all
of the following criteria
- SCI classification (American Spinal Injury Association Impairment Scale (AIS)
C or D))
- At least 6 months post injury-onset to ensure a stable neurological condition
- Able to walk at least 10m with or without a walking aid and/or braces
- Walking speed at inclusion between 0 3 and 1 0 m/s (measured with the 10MWT)
- A rehabilitation goal on improving (functional) walking capacity
- Age >18 years
- Willingness and ability to cancel/postpone other interventions or treatments
aimed at improving functional balance capacity or participation during the
study duration

Exclusion Criteria

The main exclusion criteria are
- Other neurological or lower limb impairments in addition to the iSCI
- Walking or balance problems prior to the iSCI
- Expected life events during the study period that influence the activity
level of the patient (such as retirement, parenthood, a new job or an operation)
- Within the first 6 months after a previous GRAIL trajectory
- Scheduled Botulinum Toxin (Botox) injections during the intervention period.
- Insufficient understanding or mastery of the Dutch language to understand
training and measurement instructions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Walking speed measured with the 2 minutes walking test (2MWT).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>2. Functional walking ability measured with the spinal cord injury - functional<br /><br>ambulation profile (SCI-FAP)<br /><br>3. Participation measured with the Utrecht scale for evaluation of<br /><br>rehabilitation-participation (USER-P).<br /><br>4. Two rehabilitation goals, one on the activity level and one on participation<br /><br>level of the ICF, assessed with the Goal Attainment Scaling (GAS)<br /><br>5. Walking speed measured with the 2 minute walking test (2MWT) during<br /><br>self-paced treadmill walking on the GRAIL.<br /><br>6. Balance confidence measured with the activities-specific balance confidence<br /><br>(ABC) scale<br /><br>7. Patients* experience on the different interventions will be captured with a<br /><br>customized questionnaire.</p><br>
© Copyright 2025. All Rights Reserved by MedPath